Source / episode info
- **Episode:**271
- **Title:**Divine Intervention Episode 271 – The NBME and COPD (+ 2CK Courses 11/12-14).
- **Published:**2020-11-05
- Source:Episode page
One-liner
This episode provides a comprehensive review of COPD pathophysiology (emphysema vs chronic bronchitis), diagnostic criteria ({FEV}_1/{FVC} ratio, {DLCO}), management strategies for both stable and acute exacerbations, and key differential diagnoses compared to asthma.
High-yield summary
- Diagnosis: The hallmark of COPD is airflow limitation that is not fully reversible. Spirometry diagnosis requires an {FEV}_1/{FVC} ratio < 70\%.
- Pathophysiology Distinction: Emphysema involves the loss of lung elastic recoil (leading to decreased {DLCO}), while Chronic Bronchitis is defined by a productive cough ( 3 months/year for 2 consecutive years).
- Alpha-1 Antitrypsin Deficiency: This genetic deficiency causes early-onset COPD and must be suspected in young patients with severe lung disease.
- Oxygen Therapy Criteria (Rule of Mines): Home oxygen therapy is indicated if {PaO}_2 55 { mmHg} OR {SpO}_2 80\%, or if the patient has evidence of pulmonary hypertension or right heart failure.
- Exacerbation Management: Acute exacerbations require a short-acting bronchodilator (IV _2-agonist preferred), IV corticosteroids, and antibiotics (covering H. influenzae). Non-invasive ventilation ({NIV}) is indicated to reduce mortality if contraindications are absent.
- Drug Side Effects: Anticholinergic agents (LAMA) cause dry mouth and are contraindicated in BPH or angle-closure glaucoma; _2-agonists can cause tachycardia/tremors due to _1 activity.
Learning objectives
- Differentiate the pathophysiology and spirometric findings between COPD (emphysema vs chronic bronchitis) and asthma.
- Apply diagnostic criteria for COPD, including \text{FEV}_1/\text{FVC} ratio and \text{DLCO}.
- Determine appropriate oxygen therapy guidelines based on partial pressure (\text{PaO}_2) and saturation (\text{SpO}_2).
- Manage acute COPD exacerbations using a stepwise approach involving bronchodilators, steroids, antibiotics, and potentially \text{NIV}.
- Recognize the clinical presentation and management of Alpha-1 antitrypsin deficiency.